Rollins Shorts at Year High as Peers Rally Harder
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
ROL carries the highest short interest in its peer group into Thursday's Q3 print, with 5.95% of the free float sold short. The closest US comparables, RSG, WM, and WCN, gained between 6% and 10% on the week. Rollins managed 2.5%.
That underperformance sits alongside a positioning shift that has no parallel in at least a year. Short interest stood at 11.9 million shares in early September. It reached 28.6 million by October 20, a near-tripling in under seven weeks. The borrow market remains unstressed despite the buildup: availability is 1,492%, meaning roughly 15 shares can still be borrowed for every one currently out on loan, and the cost to borrow is 0.44%, down 18% on the week. The short position is large by this stock's own history, but it was built cheaply and without any friction in the lending market. What has changed since the most recent note is options sentiment. The put/call ratio on Tuesday hit 1.00, nearly three standard deviations above its 20-day average of 0.48 and close to the 52-week peak of 1.26. For most of October, before this week, the ratio had been running between 0.39 and 0.42. That sudden shift to near-parity between puts and calls, on a stock where calls had dominated for months, is the sharpest change in the pre-earnings setup.
The analyst debate has been settled in one direction for weeks. Every firm that moved a target since mid-September went lower, and the moves were large. Morgan Stanley remains the only firm with an Overweight rating, and even it trimmed its target to $43 from $45 on October 13. JP Morgan, Bernstein, UBS, Citigroup, and BNP Paribas all hold neutral ratings with targets now clustered between $32 and $36, straddling the current price of $33.45. Citigroup's $32 target is already below where the stock trades. The consensus concern is the same across firms: organic revenue has missed the company's own 7% to 8% growth target for three consecutive quarters, residential lead volumes tied to Orkin have weakened, and the bear case names AI-driven search as a structural headwind that directs pest-control queries toward smaller local operators. The bull case rests on the durability of the contracted revenue model, commercial organic growth of 7.2% in Q2 that held up better than the residential side, and the view that discipline on M&A and pricing can underpin margins even as the top line disappoints.
One structural fact overhangs the stock beyond the quarter. ORTEX puts the probability at 91% that Rollins is deleted from the CRSP US Large index and at 90% from the CRSP US Mid index at the December 2026 Quarterly Review, with a rank date of December 4 and a trade date of December 22. The stock would need to close above $43.92 to stay in, a price 31.7% above today's level. The combined index-tracker selling from those two deletions is estimated at $130 million. A simultaneous CRSP US Small inclusion with 87% probability implies $164 million of buying pressure, partially offsetting that. These are ORTEX forecasts, not confirmed by the index provider, and they depend on where the stock is on the rank date, not today.
The last two quarterly prints ended with the stock down roughly 10% to 11% on the day and down a further point or two over the following five sessions. Thursday's number will test whether the combination of entrenched short positioning, defensive options sentiment, and a unanimous analyst downgrade cycle reflects a setup that was already priced in, or one that has further to run.
Stocks in this article
See the live data behind this article on ORTEX.
Open ROL on ORTEX →How this article was generated
- Generated
- 22 Oct 2026, 04:04
- Data as of
- 22 Oct 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex RebalancePrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.